Gemcitabine and cisplatin in patients with carcinoma of unknown primary site

Medical Oncology

Volumn 28, Issue 2, 2011, Pages 591-596

  Isik, Metin ^a   Seker, Mehmet M ^a   Odabas, Hatice ^a   Kos, Fahriye T ^a   Uncu, Dogan ^a   Zengin, Nurullah ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Carcinoma of unknown primary; Chemotherapy; Cisplatin; Gemcitabine

Indexed keywords

CISPLATIN; GEMCITABINE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BONE CANCER; BRAIN CANCER; CANCER LOCALIZATION; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL ARTICLE; EPITHELIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CANCER; LYMPH NODE METASTASIS; MALE; METASTASIS; OVERALL SURVIVAL; PANCREAS CANCER; PERITONEUM CANCER; PLEURA CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL CARCINOMA; SURRENAL GLAND CANCER; TREATMENT RESPONSE; UNDIFFERENTIATED CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; RETROSPECTIVE STUDIES;

EID: 79960297059     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9465-8     Document Type: Article

References (34)

1. S Culine A Lortholary JJ Voigt, et al. 2003 Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized Phase II study. Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01) J Clin Oncol 21 3479 3482 12972523 10.1200/JCO.2003.12.104 1:CAS:528:DC%2BD2cXpsVKjtbw%3D (Pubitemid 46594080)
2. Palmeri S, Lorusso V, Palmeri L, Vaglica M, Porta C, Nortilli R, Ferraú F, Comella G, Massidda B, Danova M. Carcinomas of Unknown Primary Italian Study Group. Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site: results of an Italian multicenter, randomized, phase II study. Cancer. 2006;107:2898-905. (Pubitemid 44937045)
3. N Pavlidis K Fizazi 2005 Cancer of unknown primary (CUP) Crit Rev Oncol Hematol 54 243 250 15890271 10.1016/j.critrevonc.2004.10.002 (Pubitemid 40693686)
4. FA Greco JD Hainsworth 1992 Tumors of unknown origin CA Cancer J Clin 42 96 115 1540854 10.3322/canjclin.42.2.96 1:STN:280:DyaK387nsVShtA%3D%3D
5. S Culine A Kramar M Saghatchian, et al. 2002 Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site J Clin Oncol 20 4679 4683 12488413 10.1200/JCO.2002.04.019 (Pubitemid 36025285)
6. N Pavlidis P Kosmidis D Skarlos, et al. 1992 Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study Ann Oncol 3 631 634 1450045 1:STN:280:DyaK3s%2FotFehtQ%3D%3D
7. R Bugat A Bataillard T Lesimple, et al. 2003 Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site Br J Cancer 89 suppl 1 S59 S66 12915904 10.1038/sj.bjc.6601085 (Pubitemid 37076150)
8. Kodaire M, Takahashi S, Yamada S, Ueda K, Mishima Y, Takeuchi K, Yamamoto N, Ishikawa Y, Yokoyama M, Saotome T, Terui Y, Hatake K. Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy. Ann Oncol. 2009; 17: [Epub Ahead of print].
9. AB Miller B Hoogstraten M Staquet, et al. 1981 Reporting results of cancer treatment Cancer 47 207 214 7459811 10.1002/1097-0142(19810101)47: 1<207::AID-CNCR2820470134>3.0.CO;2-6 1:STN:280:DyaL3M7htFOltw%3D%3D (Pubitemid 11167383)
10. KR Hess MC Abbruzzese R Lenzi MN Raber JL Abbruzzese 1999 Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma Clin Cancer Res 5 3403 3410 10589751 1:STN:280: DC%2BD3c%2FlsFKlug%3D%3D
11. RM Goldberg FP Smith W Ueno, et al. 1986 5-Fluorouracil, adriamycin and mitomycin in the treatment of adenocarcinoma of unknown primary J Clin Oncol 4 395 399 3754004 1:STN:280:DyaL287kt12jtA%3D%3D (Pubitemid 16133093)
12. J Treat SC Falchuk C Tremblay, et al. 1989 Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary Eur J Clin Oncol 25 1053 1059 10.1016/0277-5379(89)90387-8 1:STN:280:DyaL1MzjvVGhtg%3D%3D (Pubitemid 19171316)
13. RL Woods RM Fox MHN Tattersall, et al. 1980 Metastatic adenocarcinomas of unknown primary: a randomized study of two combination-chemotherapy regimens N Engl J Med 303 87 89 6991941 10.1056/NEJM198007103030205 1:STN:280: DyaL3c3gvF2jtw%3D%3D (Pubitemid 10073317)
14. ST Milliken MHN Tattersall RL Woods, et al. 1987 Metastatic adenocarcinoma of unknown primary site: a randomized study of two combination chemotherapy regimens Eur J Cancer Clin Oncol 23 1645 1650 2448145 10.1016/0277-5379(87)90443-3 1:STN:280:DyaL1c7htFygtg%3D%3D (Pubitemid 18044641)
15. RT Eagan TM Therneau J Rubin HJ Long AJ Schutt 1987 Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial Am J Clin Oncol 10 82 85 3548315 10.1097/00000421-198702000-00018 1:STN:280:DyaL2s7ltlaisg%3D%3D (Pubitemid 17007913)
16. H Anderson N Thatcher E Randin, et al. 1983 VAC (vincristine, Adriamycin and cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site Eur J Cancer Clin Oncol 19 49 52 6687868 10.1016/0277-5379(83) 90397-8 1:STN:280:DyaL3s3gvFOrsQ%3D%3D (Pubitemid 13138715)
17. ES De Campos LP Menace J Radford, et al. 1994 Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/EP) Cancer 73 470 475 8293415 10.1002/1097- 0142(19940115)73:2<470::AID-CNCR2820730236>3.0.CO;2-7 (Pubitemid 24030630)
18. MN Raber J Faintuch JL Abbruzzese, et al. 1991 Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin Ann Oncol 2 519 520 1911461 1:STN:280:DyaK38%2FgtFKhuw%3D%3D
19. I Gill P Guaglianone SM Grunberg, et al. 1991 High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primary Anticancer Res 11 1231 1235 1888154 1:STN:280:DyaK3Mzmt1ertw%3D%3D
20. FA Greco HA Burris JB Erland, et al. 2000 Carcinoma of unknown primary site. Long-term follow up after treatment with paclitaxel, carboplatin and etoposide Cancer 89 2655 2660 11135228 10.1002/1097-0142(20001215)89:12<2655: :AID-CNCR19>3.0.CO;2-9 1:STN:280:DC%2BD3M7gvVakug%3D%3D (Pubitemid 32012427)
21. FA Greco JB Erland LH Morrissey, et al. 2000 Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin Ann Oncol 11 211 215 10761758 10.1023/A:1008369812295 1:STN:280:DC%2BD3c3it1eqtw%3D%3D (Pubitemid 30148737)
22. FA Greco HA Burris S Litchy, et al. 2002 Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a minnie pearl cancer research network study J Clin Oncol 20 1651 1656 11896116 10.1200/JCO.20.6.1651 1:CAS:528:DC%2BD38XivFeitrc%3D (Pubitemid 34260547)
23. FA Greco GI Rodriguez DW Shaffer, et al. 2004 Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a minnie pearl cancer research network phase II trial Oncologist 9 644 652 15561808 10.1634/theoncologist.9-6-644 1:CAS:528: DC%2BD2MXhs1ykuw%3D%3D (Pubitemid 39546405)
24. Greco FA, Litchy S, Dannaher C, et al. Carcinoma of unknown primary site with unfavorable characteristics: survival of 396 patients after treatment with five consecutive phase II trials by the minnie pearl cancer research network. Proc Am Soc Clin Oncol. 2004; 22:14S. Abstract 4186.
25. JD Hainsworth HA Burris SW Calvert, et al. 2001 Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the minnie pearl cancer research network Cancer Invest 19 335 339 11405172 10.1081/CNV-100103127 1:CAS:528:DC%2BD3MXkvFaqtrs%3D (Pubitemid 32525180)
26. JD Hainsworth DR Spigel EL Raefsky, et al. 2005 Combination chemotherapy of gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a minnie pearl cancer research network phase II trial Cancer 104 1992 1997 16130138 10.1002/cncr.21416 1:CAS:528:DC%2BD2MXht1aqs77O (Pubitemid 41513185)
27. Schneider BJ, El-Rayes B, Muler JH, Philip PA, Kalemkerian GP, Griffith KA, Zalupski MM. Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site. Cancer. 2007;110(4):770-5. (Pubitemid 47257653)
28. C Balana J-L Manzano I Moreno, et al. 2003 A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site Ann Oncol 14 1425 1429 12954583 10.1093/annonc/mdg361 1:STN:280:DC%2BD3svhsFSjtA%3D%3D (Pubitemid 37185290)
29. N Pavlidis K Fizazi 2009 Carcinoma of unknown primary (CUP) Crit Rev Oncol Hematol 69 271 278 18977667 10.1016/j.critrevonc.2008.09.005
30. JE Dowell AM Garrett Y Shyr DH Johnson KR Hande 2001 A randomized phase II trial in patients with carcinoma of unknown primary site Cancer 91 592 597 11169943 10.1002/1097-0142(20010201)91:3<592::AID-CNCR1039>3.0.CO;2-5 1:STN:280:DC%2BD3M7ktFOguw%3D%3D (Pubitemid 32105706)
31. K Yonemori M Ando T Shibata N Katsumata, et al. 2006 Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy J Cancer Res Clin Oncol 132 635 642 16791594 10.1007/s00432-006-0110-z 1:CAS:528: DC%2BD28XoslWmsLc%3D (Pubitemid 44310329)
32. S Culine M Fabbro M Ychou G Romieu D Cupissol F Pinguet 2002 Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site Cancer 94 840 846 11857320 10.1002/cncr.10264 1:CAS:528: DC%2BD38XhsVOju70%3D (Pubitemid 34132315)
33. Pentheroudakis G, Briasoulis E, Kalofonos HP, Fountzilas G, Economopoulos T, Samelis G, Koutras A, Karina M, Xiros N, Samantas E, Bamias A, Pavlidis N. Hellenic Cooperative Oncology Group. Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study. Acta Oncol. 2008;47:1148-55.
34. D Poussel S Culine C Becht G Romieu M Fabbro M Ychou D Cupissol F Pinguet 2003 Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary site Anticancer Res 23 2801 2804 (Pubitemid 36969817)